Epigallocatechin-3-gallate enhances clearance of phosphorylated tau in primary neurons

Nutritional Neuroscience

Volumn 19, Issue 1, 2016, Pages 21-31

  Chesser, Adrianne S ^a   Ganeshan, Veena ^a   Yang, Jonathan ^a   Johnson, Gail V W ^a  

^a UNIVERSITY OF ROCHESTER   (United States)

Author keywords

Alzheimer disease; Autophagy; EGCG; Green tea; NDP52; Tau

Indexed keywords

ADAPTOR PROTEIN; EPIGALLOCATECHIN GALLATE; NDP52 PROTEIN; PHOSPHODIESTERASE; PROTEIN P62; TAU PROTEIN; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; ANTIOXIDANT; CATECHIN; MAPT PROTEIN, HUMAN; MESSENGER RNA; NFE2L2 PROTEIN, HUMAN; NFE2L2 PROTEIN, RAT; NUCLEAR DOT PROTEIN 52, HUMAN; NUCLEAR PROTEIN; P62 PROTEIN, HUMAN; PLANT MEDICINAL PRODUCT; RNA BINDING PROTEIN; TEA;

ANIMAL CELL; ARTICLE; AUTOPHAGY; CELL VIABILITY; CLEARANCE; CONTROLLED STUDY; EMBRYO; GENE EXPRESSION; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RADIOIMMUNOPRECIPITATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; ANIMAL; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; GENETICS; METABOLISM; MICROTUBULE; NERVE CELL; PHOSPHORYLATION; SPRAGUE DAWLEY RAT; TEA; TUMOR CELL LINE;

ANIMALS; ANTIOXIDANTS; AUTOPHAGY; CATECHIN; CELL LINE, TUMOR; HUMANS; MICROTUBULES; NEURONS; NF-E2-RELATED FACTOR 2; NUCLEAR PROTEINS; PHOSPHORYLATION; PHYTOCHEMICALS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; RNA-BINDING PROTEINS; TAU PROTEINS; TEA;

EID: 84961990607     PISSN: 1028415X     EISSN: 14768305     Source Type: Journal    
DOI: 10.1179/1476830515Y.0000000038     Document Type: Article

References (69)

1. Chun W, Johnson GV. The role of tau phosphorylation and cleavage in neuronal cell death. Front Biosci 2007;12:733–56.
2. Wood JG, Mirra SS, Pollock NJ, Binder LI. Neurofibrillary tangles of Alzheimer disease share antigenic determinants with the axonal microtubule-associated protein tau (tau). Proc Natl Acad Sci USA 1986;83(11):4040–3.
3. Lee VM, Balin BJ, Otvos L, Jr, Trojanowski JQ. A68: a major subunit of paired helical filaments and derivatized forms of normal tau. Science 1991;251(4994):675–8.
4. Gendron TF, Petrucelli L. The role of tau in neurodegeneration. Mol Neurodeg 2009;4:13.
5. Duyckaerts C, Bennecib M, Grignon Y, Uchihara T, He Y, Piette F, et al. Modeling the relation between neurofibrillary tangles and intellectual status. Neurobiol Aging 1997;18(3):267–73.
6. Murray ME, Lowe VJ, Graff-Radford NR, Liesinger AM, Cannon A, Przybelski SA, et al. Clinicopathologic and 11CPittsburgh compound B implications of Thal amyloid phase across the Alzheimer’s disease spectrum. Brain 2015;138(5): 1370–81.
7. Braak H, Braak E. Neuropathological stageing of Alzheimerrelated changes. Acta Neuropathol 1991;82(4):239–59.
8. Gotz J, Xia D, Leinenga G, Chew YL, Nicholas H. What renders TAU toxic. Front Neurol 2013;4:72.
9. David DC, Layfield R, Serpell L, Narain Y, Goedert M, Spillantini MG. Proteasomal degradation of tau protein. J Neurochem 2002;83(1):176–85.
10. Zhang JY, Liu SJ, Li HL, Wang JZ. Microtubule-associated protein tau is a substrate of ATP/Mg(2+)-dependent proteasome protease system. J Neural Trans 2005;112(4):547–55.
11. Wang Y, Martinez-Vicente M, Kruger U, Kaushik S, Wong E, Mandelkow EM, et al. Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing. Hum Mol Genet 2009;18(21):4153–70.
12. Kruger U, Wang Y, Kumar S, Mandelkow EM. Autophagic degradation of tau in primary neurons and its enhancement by trehalose. Neurobiol Aging 2012;33(10):2291–305.
13. Caccamo A, Magri A, Medina DX, Wisely EV, Lopez-Aranda MF, Silva AJ, et al. mTor regulates tau phosphorylation and degradation: implications for Alzheimer’s disease and other tauopathies. Aging Cell 2013;12(3):370–80.
14. Dolan PJ, Johnson GV. A caspase cleaved form of tau is preferentially degraded through the autophagy pathway. J Biol Chem 2010;285(29):21978–87.
15. Chesser A, Pritchard S, Johnson GVW. Tau clearance mechanisms and their possible role in the pathogenesis of Alzheimer disease. Front Neurol 2013;4:122. doi:10.3389/fneur.2013.00122.
16. Jo C, Gundemir S, Pritchard S, Jin YN, Rahman I, Johnson GV. Nrf2 reduces levels of phosphorylated tau protein by inducing autophagy adaptor protein NDP52. Nat Commun 2014;5:3496.
17. Lei Z, Brizzee C, Johnson GV. BAG3 facilitates the clearance of endogenous tau in primary neurons. Neurobiol Aging 2015; 36(1):241–8.
18. Schaeffer V, Lavenir I, Ozcelik S, Tolnay M, Winkler DT, Goedert M. Stimulation of autophagy reduces neurodegeneration in a mouse model of human tauopathy. Brain 2012;135(Pt 7): 2169–77.
19. Rodriguez-Navarro JA, Rodriguez L, Casarejos MJ, Solano RM, Gomez A, Perucho J, et al. Trehalose ameliorates dopaminergic and tau pathology in parkin deleted/tau overexpressing mice through autophagy activation. Neurobiol Dis 2010;39(3): 423–38.
20. Johansen T, Lamark T. Selective autophagy mediated by autophagic adapter proteins. Autophagy 2011;7(3):279–96.
21. Pankiv S, Clausen TH, Lamark T, Brech A, Bruun JA, Outzen H, et al. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem 2007;282(33):24131–45.
22. Ivanov S, Roy CR. NDP52: the missing link between ubiquitinated bacteria and autophagy. Nat Immunol 2009;10(11):1137–9.
23. von Muhlinen N, Akutsu M, Ravenhill BJ, Foeglein A, Bloor S, Rutherford TJ, et al. LC3C, bound selectively by a noncanonical LIR motif in NDP52, is required for antibacterial autophagy. Mol Cell 2012;48(3):329–42.
24. Morriswood B, Ryzhakov G, Puri C, Arden SD, Roberts R, Dendrou C, et al. T6BP and NDP52 are myosin VI binding partners with potential roles in cytokine signalling and cell adhesion. J Cell Sci 2007;120(Pt 15):2574–85.
25. Tumbarello DA, Waxse BJ, Arden SD, Bright NA, Kendrick-Jones J, Buss F. Autophagy receptors link myosin VI to autophagosomes to mediate Tom1-dependent autophagosome maturation and fusion with the lysosome. Nat Cell Biol 2012;14(10):1024–35.
26. Jain A, Lamark T, Sjottem E, Larsen KB, Awuh JA, Overvatn A, et al. p62/SQSTM1 is a target gene for transcription factorNRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription. J Biol Chem 2010; 285(29):22576–91.
27. Ramsey CP, Glass CA, Montgomery MB, Lindl KA, Ritson GP, Chia LA, et al. Expression of Nrf2 in neurodegenerative diseases. J Neuropathol Exp Neurol 2007;66(1):75–85.
28. Kanninen K, Malm TM, Jyrkkanen HK, Goldsteins G, Keksa-Goldsteine V, Tanila H, et al. Nuclear factor erythroid 2-related factor 2 protects against beta amyloid. Mol Cell Neurosci 2008; 39(3):302–13.
29. Kanninen K, Heikkinen R, Malm T, Rolova T, Kuhmonen S, Leinonen H, et al. Intrahippocampal injection of a lentiviral vector expressing Nrf2 improves spatial learning in a mouse model of Alzheimer’s disease. Proc Natl Acad Sci USA 2009; 106(38):16505–10.
30. Boettler U, Sommerfeld K, Volz N, Pahlke G, Teller N, Somoza V, et al. Coffee constituents as modulators of Nrf2 nuclear translocation and ARE (EpRE)-dependent gene expression. J Nutr Biochem 2011;22(5):426–40.
31. Ernst IM, Wagner AE, Schuemann C, Storm N, Hoppner W, Doring F, et al. Allyl-, butyl-and phenylethyl-isothiocyanate activate Nrf2 in cultured fibroblasts. Pharmacol Res 2011; 63(3):233–40.
32. Fischedick JT, Standiford M, Johnson DA, De Vos RC, Todorovic S, Banjanac T, et al. Activation of antioxidant response element in mouse primary cortical cultures with sesquiterpene lactones isolated from Tanacetum parthenium. Planta Med 2012;78(16):1725–30.
33. Lee JH, Khor TO, Shu L, Su ZY, Fuentes F, Kong AN. Dietary phytochemicals and cancer prevention: Nrf2 signaling, epigenetics, and cell death mechanisms in blocking cancer initiation and progression. Pharmacol Ther 2012;137(2):153–71.
34. Su ZY, Shu L, Khor TO, Lee JH, Fuentes F, Kong AN. A perspective on dietary phytochemicals and cancer chemoprevention: oxidative stress, nrf2, and epigenomics. Top Curr Chem 2013; 329:133–62.
35. Vicente SJ, Ishimoto EY, Torres EA. Coffee modulates transcription factor Nrf2 and highly increases the activity of antioxidant enzymes in rats. J Agric Food Chem 2014;62(1):116–22.
36. Wagner AE, Ernst I, Iori R, Desel C, Rimbach G. Sulforaphane but not ascorbigen, indole-3-carbinole and ascorbic acid activates the transcription factor Nrf2 and induces phase-2 and antioxidant enzymes in human keratinocytes in culture. Exp Dermatol 2010;19(2):137–44.
37. Zheng Y, Morris A, Sunkara M, Layne J, Toborek M, Hennig B. Epigallocatechin-gallate stimulates NF-E2-related factor and heme oxygenase-1 via caveolin-1 displacement. J Nutr Biochem 2012;23(2):163–8.
38. Scapagnini G, Vasto S, Abraham NG, Caruso C, Zella D, Fabio G. Modulation of Nrf2/ARE pathway by food polyphenols: a nutritional neuroprotective strategy for cognitive and neurodegenerative disorders. Mol Neurobiol 2011;44(2):192–201.
39. Sun AY, Wang Q, Simonyi A, Sun GY. Botanical phenolics and neurodegeneration. In: Benzie IFF, Wachtel-Galor S, editors. Herbal medicine: biomolecular and clinical aspects. 2nd ed. Boca Raton (FL): CRC Press; 2011. Chapter 11.
40. Kim HV, Kim HY, Ehrlich HY, Choi SY, Kim DJ, Kim Y. Amelioration of Alzheimer’s disease by neuroprotective effect of sulforaphane in animal model. Amyloid 2013;20(1):7–12.
41. Zhang R, Miao QW, Zhu CX, Zhao Y, Liu L, Yang J, et al. Sulforaphane ameliorates neurobehavioral deficits and protects the brain from amyloid beta deposits and peroxidation in mice with Alzheimer-like lesions. Am J Alzheimer’s Dis Other Dement 2015;30(2):183–91.
42. Kim HS, Quon MJ, Kim JA. New insights into the mechanisms of polyphenols beyond antioxidant properties; lessons from the green tea polyphenol, epigallocatechin 3-gallate. Redox Biol 2014;2:187–95.
43. Mandel SA, Amit T, Kalfon L, Reznichenko L, Youdim MB. Targeting multiple neurodegenerative diseases etiologies with multimodal-acting green tea catechins. J Nutr 2008;138(8): 1578S–83S.
44. Ehrnhoefer DE, Bieschke J, Boeddrich A, Herbst M, Masino L, Lurz R, et al. EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers. Nat Struct Mol Biol 2008; 15(6):558–66.
45. Park HM, Kim JA, Kwak MK. Protection against amyloid beta cytotoxicity by sulforaphane: role of the proteasome. Arch Pharmacol Res 2009;32(1):109–15.
46. Lin CL, Chen TF, Chiu MJ, Way TD, Lin JK. Epigallocatechin gallate (EGCG) suppresses beta-amyloid-induced neurotoxicity through inhibiting c-Abl/FE65 nuclear translocation and GSK3 beta activation. Neurobiol Aging 2009;30(1):81–92.
47. Rezai-Zadeh K, Shytle D, Sun N, Mori T, Hou H, Jeanniton D, et al. Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice. J Neurosci 2005;25(38): 8807–14.
48. Na HK, Kim EH, Jung JH, Lee HH, Hyun JW, Surh YJ. (−-)-Epigallocatechin gallate induces Nrf2-mediated antioxidant enzyme expression via activation of PI3 K and ERK in human mammary epithelial cells. Arch Biochem Biophys 2008;476(2): 171–7.
49. Augustinack J, Schneider A, Mandelkow E-M, Hyman B. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer’s disease. Acta Neuropathol 2002;103(1):26–35.
50. Jo C, Kim S, Cho SJ, Choi KJ, Yun SM, Koh YH, et al. Sulforaphane induces autophagy through ERK activation in neuronal cells. FEBS Lett 2014;588(17):3081–8.
51. Irimie AI, Braicu C, Zanoaga O, Pileczki V, Gherman C, Berindan-Neagoe I, et al. Epigallocatechin-3-gallate suppresses cell proliferation and promotes apoptosis and autophagy in oral cancer SSC-4 cells. OncoTargets Ther 2015;8:461–70.
52. Kim HS, Montana V, Jang HJ, Parpura V, Kim JA. Epigallocatechin gallate (EGCG) stimulates autophagy in vascular endothelial cells: a potential role for reducing lipid accumulation. J Biol Chem 2013;288(31):22693–705.
53. Gu HF, Nie YX, Tong QZ, Tang YL, Zeng Y, Jing KQ, et al. Epigallocatechin-3-gallate attenuates impairment of learning and memory in chronic unpredictable mild stress-treated rats by restoring hippocampal autophagic flux. PLoS One 2014; 9(11):e112683.
54. Boland B, Kumar A, Lee S, Platt FM, Wegiel J, Yu WH, et al. Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer’s disease. J Neurosci 2008;28(27):6926–37.
55. Komatsu M, Kurokawa H, Waguri S, Taguchi K, Kobayashi A, Ichimura Y, et al. The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat Cell Biol 2010;12(3): 213–23.
56. Salminen A, Kaarniranta K, Haapasalo A, Hiltunen M, Soininen H, Alafuzoff I. Emerging role of p62/sequestosome-1 in the pathogenesis of Alzheimer’s disease. Prog Neurobiol 2012;96(1):87–95.
57. Howes MJ, Houghton PJ. Ethnobotanical treatment strategies against Alzheimer’s disease. Curr AlzheimerRes 2012;9(1):67–85.
58. Romeo L, Intrieri M, D’Agata V, Mangano NG, Oriani G, Ontario ML, et al. The major green tea polyphenol, (−)-epigallocatechin-3-gallate, induces heme oxygenase in rat neurons and acts as an effective neuroprotective agent against oxidative stress. J Am College Nutr 2009;28(Suppl 49):2S–9S.
59. Han J, Wang M, Jing X, Shi H, Ren M, Lou H. (−)-Epigallocatechin gallate protects against cerebral ischemiainduced oxidative stress via Nrf2/ARE signaling. Neurochem Res 2014;39(7):1292–9.
60. Schroeder EK, Kelsey NA, Doyle J, Breed E, Bouchard RJ, Loucks FA, et al. Green tea epigallocatechin 3-gallate accumulates in mitochondria and displays a selective antiapoptotic effect against inducers of mitochondrial oxidative stress in neurons. Antioxid Redox Signal 2009;11(3):469–80.
61. Babu JR, Geetha T, Wooten MW. Sequestosome 1/p62 shuttles polyubiquitinated tau for proteasomal degradation. J Neurochem 2005;94(1):192–203.
62. Balasubramanian S, Eckert RL. Green tea polyphenol and curcumin inversely regulate human involucrin promoter activity via opposing effects on CCAAT/enhancer-binding protein function. J Biol Chem 2004;279(23):24007–14.
63. Yao C, Zhang J, Liu G, Chen F, Lin Y. Neuroprotection by (−)-epigallocatechin-3-gallate in a rat model of stroke is mediated through inhibition of endoplasmic reticulum stress. Mol Med Rep 2014;9(1):69–76.
64. Thakur VS, Gupta K, Gupta S. Green tea polyphenols increase p53 transcriptional activity and acetylation by suppressing class I histone deacetylases. Int J Oncol 2012;41(1):353–61.
65. Tran PL, Kim SA, Choi HS, Yoon JH, Ahn SG. Epigallocatechin-3-gallate suppresses the expression of HSP70 and HSP90 and exhibits anti-tumor activity in vitro and in vivo. BMC Cancer 2010;10:276.
66. Weinreb O, Amit T, Youdim MBH. A novel approach of proteomics and transcriptomics to study the mechanism of action of the antioxidant–iron chelator green tea polyphenol (−)-epigallocatechin-3-gallate. Free Radic Biol Med 2007;43(4):546–56.
67. Yin Z, Henry EC, Gasiewicz TA. (−)-Epigallocatechin-3-gallate is a novel Hsp90 inhibitor. Biochemistry 2009;48(2):336–45.
68. Dickey CA, Dunmore J, Lu B, Wang JW, Lee WC, Kamal A, et al. HSP induction mediates selective clearance of tau phosphorylated at proline-directed Ser/Thr sites but not KXGS (MARK) sites. FASEB J 2006;20(6):753–5.
69. Singh M, Arseneault M, Sanderson T, Murthy V, Ramassamy C. Challenges for research on polyphenols from foods in Alzheimer’s disease: bioavailability, metabolism, and cellular and molecular mechanisms. J Agric Food Chem 2008;56(13):4855–73.